Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 571 AL 585

Aβ-PET pathology accumulation index: Ready for the clinic?

Kerchner GA, Filippi M.

Neurology. 2020 Nov 24;95(21):943-944. doi: 10.1212/WNL.0000000000011060. Epub 2020 Oct 19.

Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches

Ejaz HW, Wang W, Lang M.

Int J Mol Sci. 2020 Oct 16;21(20):7660. doi: 10.3390/ijms21207660.

The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease

Bukke VN, Villani R, Archana M, Wawrzyniak A, Balawender K, Orkisz S, Ferraro L, Serviddio G, Cassano T.

Int J Mol Sci. 2020 Oct 19;21(20):7739. doi: 10.3390/ijms21207739.

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics

Paul D, Chipurupalli S, Justin A, Raja K, Mohankumar SK.

J Pharmacol Toxicol Methods. 2020 Nov-Dec;106:106932. doi: 10.1016/j.vascn.2020.106932. Epub 2020 Oct 20.

Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease

Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C.

Neuron. 2020 Dec 9;108(5):801-821. doi: 10.1016/j.neuron.2020.09.029. Epub 2020 Oct 22.

Studying the Relationship of Intermittent Fasting and β-Amyloid in Animal Model of Alzheimer's Disease: A Scoping Review

Nasaruddin ML, Syed Abd Halim SA, Kamaruzzaman MA.

Nutrients. 2020 Oct 21;12(10):3215. doi: 10.3390/nu12103215.

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease

Manek E, Darvas F, Petroianu GA.

Molecules. 2020 Oct 21;25(20):4866. doi: 10.3390/molecules25204866.

Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review

Fakhri S, Pesce M, Patruno A, Moradi SZ, Iranpanah A, Farzaei MH, Sobarzo-Sánchez E.

Molecules. 2020 Oct 24;25(21):4926. doi: 10.3390/molecules25214926.

The prion-like phenomenon in Alzheimer's disease: Evidence of pathology transmission in humans

Gomez-Gutierrez R, Morales R.

PLoS Pathog. 2020 Oct 29;16(10):e1009004. doi: 10.1371/journal.ppat.1009004. eCollection 2020 Oct.

Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression

Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, Samuraki-Yokohama M, Iwasa K, Yokoyama K, Nakamura H, Yamada M.

Sci Rep. 2020 Oct 29;10(1):18627. doi: 10.1038/s41598-020-73729-2.

Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer's Disease

Dhakal S, Macreadie I.

Int J Mol Sci. 2020 Oct 28;21(21):8014. doi: 10.3390/ijms21218014.

Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics

Podleśny-Drabiniok A, Marcora E, Goate AM.

Trends Neurosci. 2020 Dec;43(12):965-979. doi: 10.1016/j.tins.2020.10.002. Epub 2020 Oct 27.

Mitochondria and cellular redox state on the route from ageing to Alzheimer's disease

Abate G, Vezzoli M, Sandri M, Rungratanawanich W, Memo M, Uberti D.

Mech Ageing Dev. 2020 Dec;192:111385. doi: 10.1016/j.mad.2020.111385. Epub 2020 Oct 28.

[Molecular Basis of Preventive Effects of Habitual Coffee Intake against Chronic Diseases]

Tamura H.

Yakugaku Zasshi. 2020;140(11):1351-1363. doi: 10.1248/yakushi.20-00150.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias